𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Metabolism of cyclic GMP in non-alcoholic fatty liver disease in morbid obesity

✍ Scribed by Amparo Urios; ML Garcia-Torres; Carla Gimenez-Garzó; Cristina Aguado; Juan A del Olmo; Carmen Marin; Miguel Civera; Fernández N Cassinello; José Ortega; Antonio Ferrandez; J Martinez-Valls; Miguel A Serra; José M Rodrigo; Vicente Felipo; Carmina Montoliu

Publisher
BioMed Central
Year
2011
Tongue
English
Weight
101 KB
Volume
11
Category
Article
ISSN
1471-2210

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatic Free Fatty Acids in Alcoholic Li
Hepatic Free Fatty Acids in Alcoholic Liver Disease and Morbid Obesity
✍ Peter G. Mavrelis; Helmut V. Ammon; John J. Gleysteen; Richard A. Komorowski; Ur 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Alcoholic liver disease is characterized by the accumulation of fat and inflammatory changes in the liver. Because free fatty acids, the precursors of triglycerides, can damage biological membranes, accumulation of free fatty acids in the liver might be in part responsible for the functional and mor

The roles of obesity and gender on the r
The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans
✍ Kayoung Lee; Jung-Ah Sung; Jun-Su Kim; Tae-Jin Park 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

## Abstract **Background** The effect of gender and weight status on the association between metabolic risk factors and NAFLD has not been well established. This study aimed to assess the relationships among obesity, gender, metabolic risk factors, and non‐alcoholic fatty liver disease (NAFLD) in K

Non-alcoholic fatty liver disease progre
Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
✍ Judith Ertle; Alexander Dechêne; Jan-Peter Sowa; Volker Penndorf; Kerstin Herzer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 402 KB

## Abstract Non‐alcoholic fatty liver disease (NAFLD) is the most common liver disease in developed countries, and accumulating evidence suggests it as the hepatic manifestation of the metabolic syndrome (MS). Although the published prevalence of hepatocellular carcinoma (HCC) is low in NAFLD/NASH